| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Stock Option (right to buy) | Options Exercise | $0 | -663 | -100% | $0.00 | 0 | Nov 7, 2024 | Common Stock | 663 | $0.04 | Direct | F8 |
| transaction | PCVX | Stock Option (right to buy) | Options Exercise | $0 | -14.1K | -8.44% | $0.00 | 153K | Nov 7, 2024 | Common Stock | 14.1K | $2.03 | Direct | F8 |
| transaction | PCVX | Stock Option (right to buy) | Options Exercise | $0 | -16K | -7.32% | $0.00 | 203K | Nov 7, 2024 | Common Stock | 16K | $5.35 | Direct | F8 |
| transaction | PCVX | Performance Stock Option (right to buy) | Award | $0 | +198K | $0.00 | 198K | Nov 7, 2024 | Common Stock | 198K | $102.70 | Direct | F9 | |
| transaction | PCVX | Performance Restricted Stock Units | Award | $0 | +80.6K | $0.00 | 80.6K | Nov 7, 2024 | Common Stock | 80.6K | $0.00 | Direct | F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 12, 2024. |
| F2 | The price reported is a weighted-average price. The shares were sold at prices ranging from $102.19 to $103.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F3 | Shares are held directly by a trust for the benefit of the Reporting Person's daughter. |
| F4 | The price reported is a weighted-average price. The shares were sold at prices ranging from $103.28 to $104.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F5 | The price reported is a weighted-average price. The shares were sold at prices ranging from $104.405 to $105.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F6 | The price reported is a weighted-average price. The shares were sold at prices ranging from $102.09 to $103.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F7 | Shares are held directly by a trust for the benefit of the Reporting Person's son. |
| F8 | Stock Option is fully vested and exercisable. |
| F9 | As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the "Grant Date"), the Reporting Person was granted a performance stock option to purchase 197,784 shares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth and fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price)). |
| F10 | Represents the target number of shares of Issuer's Common Stock underlying an award of performance restricted stock units ("PSUs"). Each PSU represents the contingent right to receive one share of the Issuer's Common Stock. The attainment of the performance vesting condition will be based on the Issuer's percentile rank within a peer group based on total shareholder return ("TSR") during a four-year performance period that commenced on November 7, 2024, the Grant Date, subject to the Reporting Person's continuous service with the Issuer through completion of the performance period. The actual number of shares of the Issuer's Common Stock deliverable with respect to the award varies based on performance and ranges from 0% to 250% of the target number of shares. |